Editorial Board for section 'Biologics and Biosimilars'
- Nanomedicine and Nanotechnology Section
- Pharmaceutical Technology, Manufacturing and Devices Section
- Physical Pharmacy and Formulation Section
- Biopharmaceutics Section
- Drug Delivery and Controlled Release Section
- Pharmacokinetics and Pharmacodynamics Section
- Gene and Cell Therapy Section
- Drug Targeting and Design Section
- Biologics and Biosimilars Section
- Clinical Pharmaceutics Section
Please see the section webpage for more information on this section.
Please note that the order in which the Editors appear on this page is alphabetical, and follows the structure of the editorial board presented on the MDPI website under information for editors: editorial board responsibilities.
Members
Department of Pharmaceutical Sciences, College of Pharmacy, The University of Oklahoma Health Sciences Center, Oklahoma City, OK 73117, USA
Interests: cancer treatments; Quantitative Systems Pharmacology; clinical drug development
Interests: cancer treatments; Quantitative Systems Pharmacology; clinical drug development
Regenerative Medicine Laboratory, Department of Experimental Medicine, University of Genova, 16132 Genova, Italy
Interests: characterization of extracellular vesicles as theranostics; cardiotoxicity from cancer treatment; cardiac repair; paracrine communication; human perinatal stem cells
Special Issues, Collections and Topics in MDPI journals
Interests: characterization of extracellular vesicles as theranostics; cardiotoxicity from cancer treatment; cardiac repair; paracrine communication; human perinatal stem cells
Special Issues, Collections and Topics in MDPI journals
1. Associate Laboratory i4HB—Institute for Health and Bioeconomy, University Institute of Health Sciences—CESPU, 4585-116 Gandra, Portugal
2. UCIBIO—Applied Molecular Biosciences Unit, Translational Toxicology Research Laboratory, University Institute of Health Sciences (1H-TOXRUN, IUCS-CESPU), 4585-116 Gandra, Portugal
3. UNIPRO—Oral Pathology and Rehabilitation Research Unit, University Institute of Health Sciences (IUCS-CESPU), 4585-116 Gandra, Portugal
Interests: targeted anticancer therapy; targeting mitosis for cancer therapy; antimitotic agents; biological evaluation of natural and synthetic compounds; cancer biomarkers
Special Issues, Collections and Topics in MDPI journals
2. UCIBIO—Applied Molecular Biosciences Unit, Translational Toxicology Research Laboratory, University Institute of Health Sciences (1H-TOXRUN, IUCS-CESPU), 4585-116 Gandra, Portugal
3. UNIPRO—Oral Pathology and Rehabilitation Research Unit, University Institute of Health Sciences (IUCS-CESPU), 4585-116 Gandra, Portugal
Interests: targeted anticancer therapy; targeting mitosis for cancer therapy; antimitotic agents; biological evaluation of natural and synthetic compounds; cancer biomarkers
Special Issues, Collections and Topics in MDPI journals
